|1||Enrolling by invitation||
Clinical and Virological Outcome of European Patients Infected With HIV
|2||Active, not recruiting||
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
† Study has passed its completion date and status has not been verified in more than two years.